[go: up one dir, main page]

MX2012006881A - Composiciones de povidona-yodo oftalmicas no irritantes. - Google Patents

Composiciones de povidona-yodo oftalmicas no irritantes.

Info

Publication number
MX2012006881A
MX2012006881A MX2012006881A MX2012006881A MX2012006881A MX 2012006881 A MX2012006881 A MX 2012006881A MX 2012006881 A MX2012006881 A MX 2012006881A MX 2012006881 A MX2012006881 A MX 2012006881A MX 2012006881 A MX2012006881 A MX 2012006881A
Authority
MX
Mexico
Prior art keywords
povidone
compositions
iodine
iodine compositions
irritating ophthalmic
Prior art date
Application number
MX2012006881A
Other languages
English (en)
Other versions
MX364441B (es
Inventor
C Michael Samson
Bo Liang
Joseph A Capriotti
Jason Stein
Michael Weiser
Original Assignee
Foresight Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44305700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012006881(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Foresight Biotherapeutics Inc filed Critical Foresight Biotherapeutics Inc
Publication of MX2012006881A publication Critical patent/MX2012006881A/es
Publication of MX364441B publication Critical patent/MX364441B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen composiciones y métodos que comprenden povidona-yodo y una cantidad efectiva de enfriamiento de un agente químico. Las composiciones son útiles para aliviar la irritación ocular ligera, mejorar el confort ocular, y proporcionar un efecto refrescante y sensación mejoradas, cuando se aplica la solución de povidona-yodo al ojo.
MX2012006881A 2009-12-15 2010-12-15 Composiciones de povidona-yodo oftalmicas no irritantes. MX364441B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28669709P 2009-12-15 2009-12-15
PCT/US2010/060489 WO2011084473A1 (en) 2009-12-15 2010-12-15 Non-irritating ophthalmic povidone-iodine compositions

Publications (2)

Publication Number Publication Date
MX2012006881A true MX2012006881A (es) 2012-07-04
MX364441B MX364441B (es) 2019-04-26

Family

ID=44305700

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006881A MX364441B (es) 2009-12-15 2010-12-15 Composiciones de povidona-yodo oftalmicas no irritantes.

Country Status (16)

Country Link
US (1) US20130177522A1 (es)
EP (1) EP2512230A4 (es)
JP (3) JP2013514373A (es)
KR (2) KR20190049931A (es)
CN (2) CN104906580A (es)
AR (1) AR079479A1 (es)
AU (1) AU2010339993A1 (es)
BR (1) BR112012014260A2 (es)
CA (1) CA2784492C (es)
CL (1) CL2012001583A1 (es)
EC (1) ECSP12012037A (es)
HK (1) HK1211216A1 (es)
MX (1) MX364441B (es)
PE (2) PE20121498A1 (es)
TW (3) TWI561239B (es)
WO (1) WO2011084473A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
WO2011084473A1 (en) * 2009-12-15 2011-07-14 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
MX360666B (es) * 2011-05-12 2018-11-13 Foresight Biotherapeutics Inc Composiciones de yodopovidona estables con antiinflamatorios esteroides y no esteroides.
GB201114725D0 (en) * 2011-08-25 2011-10-12 Altacor Ltd Ophthalmic formulations
TW202023575A (zh) * 2011-09-16 2020-07-01 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物
CN102429862B (zh) 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
JP6161500B2 (ja) * 2012-10-05 2017-07-12 ロート製薬株式会社 ブロムフェナク含有組成物
JP6304475B2 (ja) * 2013-01-31 2018-04-04 ロート製薬株式会社 点眼剤
JP6304474B2 (ja) * 2013-01-31 2018-04-04 ロート製薬株式会社 点眼剤
LT2950783T (lt) * 2013-02-01 2019-10-25 Allergan Inc Dirbtinės ašaros, kurių sudėtyje yra natrio hialuronato ir karboksimetilceliuliozės
WO2014160579A1 (en) * 2013-03-25 2014-10-02 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
US9630909B2 (en) 2013-06-27 2017-04-25 Mylan Laboratories Ltd Process for the preparation of nepafenac
US20150064129A1 (en) * 2013-09-04 2015-03-05 Taiwan Biotech Co., Ltd. Wound healing composition
CN103877120B (zh) * 2014-04-02 2017-07-21 程予良 一种膏药
US11576973B2 (en) * 2015-10-25 2023-02-14 Iview Therapeutics, Inc. Pharmaceutical formulations that form gel in situ
JP6255134B1 (ja) * 2016-11-02 2017-12-27 ヴェローチェ・バイオファーマ・エルエルシー 耳炎の治療のための組成物および方法
WO2018193093A1 (en) 2017-04-21 2018-10-25 Novaliq Gmbh Iodine compositions
CN108853074A (zh) * 2017-05-10 2018-11-23 武汉先路医药科技股份有限公司 一种含有溴芬酸钠水合物的药物水性滴眼液及其制备方法
EP3853317A4 (en) * 2018-09-21 2022-06-22 PS Therapy Ltd. Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
KR102489633B1 (ko) * 2021-01-21 2023-01-17 주식회사태준제약 점안 조성물
US20230181625A1 (en) * 2021-12-14 2023-06-15 Harrow Ip, Llc Method and composition for treating infectious conjunctivitis
CN116850351A (zh) * 2023-05-29 2023-10-10 苏州理想眼科医院有限公司 一种具有较强抗菌作用的粘弹剂
CN117338787A (zh) * 2023-11-24 2024-01-05 南京恒道医药科技股份有限公司 一种眼用药物组合物及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU200103B (en) * 1987-04-01 1990-04-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for treating lack of epithelium
CA1303503C (en) * 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
US5849291A (en) * 1994-10-17 1998-12-15 Symbollon Corporation Opthalmic non-irritating iodine medicament
CN1204961A (zh) * 1996-09-26 1999-01-13 老笃制药株式会社 滴眼剂
PT1180017E (pt) * 1999-05-27 2010-05-28 Euro Celtique Sa Preparações com povidona-iodo para o tratamento de feridas
JP4748289B2 (ja) * 2000-06-23 2011-08-17 ライオン株式会社 点眼剤、眼科用組成物及び吸着抑制方法
KR20040068204A (ko) * 2001-12-21 2004-07-30 센주 세이야꾸 가부시키가이샤 점안제
ES2212907B1 (es) * 2003-01-20 2005-12-16 Luis Ignacio Olcina Portilla Preparados oftalmologicos a base de povidona yodada.
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
CA2548532C (en) * 2004-09-27 2014-12-02 Jan De Rijk Methods and compositions for treatment of water
CN101065139A (zh) * 2004-10-09 2007-10-31 扶瑞药业股份有限公司 眼用药剂递送系统
CN100335035C (zh) * 2004-10-25 2007-09-05 张帆 一种滴眼剂
JP2006219475A (ja) * 2004-12-28 2006-08-24 Rohto Pharmaceut Co Ltd 眼局所適用製剤
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
JP2007277135A (ja) * 2006-04-05 2007-10-25 Mie Univ 創傷治療用外用剤
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
US20090263345A1 (en) * 2008-01-28 2009-10-22 Foresight Biotherapeutics, Inc. Otic compositions for the treatment of infections of the internal and external ear in mammals
WO2009097123A1 (en) * 2008-01-28 2009-08-06 Foresight Biotherapeutics, Inc. Device for in-situ generation of povidone-iodine compositions
JP2008189677A (ja) * 2008-03-10 2008-08-21 Rohto Pharmaceut Co Ltd 洗浄剤
NZ603346A (en) * 2008-06-12 2014-05-30 Foresight Biotherapeutics Inc Povidone iodine, a novel alternative preservative for ophthalmic compositions
US8753561B2 (en) * 2008-06-20 2014-06-17 Baxter International Inc. Methods for processing substrates comprising metallic nanoparticles
WO2011084473A1 (en) * 2009-12-15 2011-07-14 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
CN102429862B (zh) * 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液

Also Published As

Publication number Publication date
EP2512230A4 (en) 2013-05-22
TWI618539B (zh) 2018-03-21
JP2013514373A (ja) 2013-04-25
TW201630614A (zh) 2016-09-01
CA2784492A1 (en) 2011-07-14
CA2784492C (en) 2020-06-30
KR20190049931A (ko) 2019-05-09
CN102811610B (zh) 2016-05-18
CL2012001583A1 (es) 2013-01-11
AR079479A1 (es) 2012-01-25
KR20120112537A (ko) 2012-10-11
AU2010339993A1 (en) 2012-07-26
PE20160526A1 (es) 2016-05-29
PE20121498A1 (es) 2012-11-30
TW201143783A (en) 2011-12-16
JP2018030871A (ja) 2018-03-01
TWI620569B (zh) 2018-04-11
CN104906580A (zh) 2015-09-16
MX364441B (es) 2019-04-26
TW201717973A (zh) 2017-06-01
NZ751915A (en) 2020-09-25
BR112012014260A2 (pt) 2015-09-15
WO2011084473A1 (en) 2011-07-14
HK1211216A1 (en) 2016-05-20
US20130177522A1 (en) 2013-07-11
JP2016028101A (ja) 2016-02-25
ECSP12012037A (es) 2012-08-31
CN102811610A (zh) 2012-12-05
TWI561239B (en) 2016-12-11
EP2512230A1 (en) 2012-10-24

Similar Documents

Publication Publication Date Title
MX364441B (es) Composiciones de povidona-yodo oftalmicas no irritantes.
MX2011013061A (es) Formulaciones oftalmicas de fluticasona y metodos de uso.
WO2010083239A3 (en) Therapeutic modulation of vaginal epithelium boundary lubrication
WO2011053792A3 (en) Methods and compositions for sustained delivery of drugs
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CA2711696C (en) Therapeutic compositions for treatment of ocular inflammatory disorders
NZ704247A (en) Compositions and treatment for eye diseases and disorders
PH12013501579A1 (en) Androgen composition for treating an opthalmic condition
NZ603345A (en) Stabilized ophthalmic galactomannan formulations
IL201479A0 (en) Titration of tapentadol
WO2011116020A3 (en) Ophthalmic formulations of cetirizine and methods of use
WO2012064667A3 (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
MX2010007295A (es) Composiciones acuosas estables de ciclosporina.
WO2012080497A3 (en) Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
GEP20196969B (en) New therapeutical composition containing apomorphine as active ingredient
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
NZ704178A (en) Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
WO2011042759A3 (en) Gel composition
WO2010104281A3 (ko) 아토피성 피부질환 개선용 조성물
WO2014099256A3 (en) Silicon-containing polyolefins in personal care applications
WO2012145470A3 (en) Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
ATE531703T1 (de) Benzochromenderivate
PH12015501538A1 (en) Topical ocular analgesic agents

Legal Events

Date Code Title Description
FG Grant or registration